During the past decade, Covance Research Unit - Daytona conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Covance Research Unit - Daytona" are "Healthy Volunteers" (5 trials) and "Healthy Participants" (1 trials). Many other conditions were trialed in "Covance Research Unit - Daytona" in a lesser frequency.

Most popular intervention types in "Covance Research Unit - Daytona" are "Drug" (6 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Auto-Injector (AI)" (1 trials), "Entrectinib Reference Formulation (F06)" (1 trials), "Entrectinib Test Formulation (F1)" (1 trials), "Etrolizumab" (1 trials) and "GDC-0134 F09 Formulation" (1 trials). Other intervention names were less common.

The vast majority of trials in "Covance Research Unit - Daytona" are 4 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Covance Research Unit - Daytona". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Covance Research Unit - Daytona, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Covance Research Unit - Daytona, 6 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".